Mahesh Manjunath Gouda, Ashwini Prabhu, Varsha Reddy SV, Rafa Jahan and Yashodhar Prabhakar Bhandary* Pages 1 - 4 ( 4 )
Background: Bleomycin (BLM) is known to cause DNA damage in the alveolar epithelial cells (AECs). It is reported that BLM is involved in the up-regulation of inflammatory molecules such as neutrophils, macrophages, chemokines and cytokines. The complex underlying mechanism for inflammation mediated progression of lung injury is still unclear. This investigation was designed to understand the molecular mechanisms associated with p53 mediated modulation of plasminogen activator inhibitor-I (PAI-I) expression and its regulation by nano-curcumin formulation. Methods: A549 cells were treated with BLM to cause the cellular damage in vitro and commercially available nano-curcumin formulation was used as an intervention. Cytotoxic effect of nano-curcumin was analyzed using Methyl thiazolyl tetrazolium (MTT) assay. Protein expressions were analyzed using western blot to evaluate the p53 mediated changes in PAI-I expression. Results: Nano-curcumin showed cytotoxicity up to 88.5 % at a concentration of 20 µg/ml after 48 h of treatment. BLM exposure to the cells activated the phosphorylation of p53, which in turn increased PAII expression. Nano-curcumin treatment showed a protective role against phosphorylation of p53 and PAI-I expression, which in turn regulated the fibro-proliferative phase of injury induced by bleomycin. Conclusion: Nano-curcumin could be used as an effective intervention to regulate the severity of lung injury, apoptosis of AECs and fibro-proliferation during pulmonary injury.
Bleomycin, alveolar basal epithelial cells, nano-curcumin, p53, PAI-1
Yenepoya University, Yenepoya Research Centre, Yenepoya University, Yenepoya Research Centre, SDM College, SDM PG Centre, SDM College, SDM PG Centre, Yenepoya University, Yenepoya Research Centre